On 27 July 2016
Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 July 2016 to consider the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on June 30, 2016 (Q1).Powered by Capital Market - Live News